BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23936024)

  • 21. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT).
    Jiao X; Ye J; Wang X; Yin X; Zhang G; Cheng X
    Med Sci Monit; 2019 Sep; 25():6788-6796. PubMed ID: 31501407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of Wnt signaling by the tumor suppressor adenomatous polyposis coli does not require the ability to enter the nucleus or a particular cytoplasmic localization.
    Roberts DM; Pronobis MI; Poulton JS; Kane EG; Peifer M
    Mol Biol Cell; 2012 Jun; 23(11):2041-56. PubMed ID: 22513088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The emerging role of KIAA1199 in cancer development and therapy.
    Liu J; Yan W; Han P; Tian D
    Biomed Pharmacother; 2021 Jun; 138():111507. PubMed ID: 33773462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIAA1199 and its biological role in human cancer and cancer cells (review).
    Zhang Y; Jia S; Jiang WG
    Oncol Rep; 2014 Apr; 31(4):1503-8. PubMed ID: 24573670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse LEF/TCF Expression in Human Colorectal Cancer Correlates with Altered Wnt-Regulated Transcriptome in a Meta-Analysis of Patient Biopsies.
    Mayer CD; Giclais SM; Alsehly F; Hoppler S
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
    LaPointe LC; Pedersen SK; Dunne R; Brown GS; Pimlott L; Gaur S; McEvoy A; Thomas M; Wattchow D; Molloy PL; Young GP
    PLoS One; 2012; 7(1):e29059. PubMed ID: 22276102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy.
    Oneyama M; Sakamoto N; Oue N; Kimura Y; Hiroshima Y; Hashimoto I; Hara K; Maezawa Y; Kano K; Aoyama T; Fujikawa H; Yamada T; Tamagawa H; Yamamoto N; Ogata T; Cho H; Ito H; Yukawa N; Shiozawa M; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Miyagi Y; Yasui W; Oshima T
    Anticancer Res; 2019 Dec; 39(12):6567-6573. PubMed ID: 31810922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
    Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
    Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Cheng C; Huang Z; Zhou R; An H; Cao G; Ye J; Huang C; Wu D
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G841-G853. PubMed ID: 32146835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer.
    Peng Q; Chen L; Wu W; Wang J; Zheng X; Chen Z; Jiang Q; Han J; Wei L; Wang L; Huang J; Ma J
    Cell Death Dis; 2018 Nov; 9(12):1146. PubMed ID: 30451837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
    Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
    Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer.
    Kohi S; Sato N; Koga A; Matayoshi N; Hirata K
    Oncotarget; 2017 Mar; 8(10):17156-17163. PubMed ID: 28179576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knockdown of KIAA1199 suppresses IL-1β-induced cartilage degradation and inflammatory responses in human chondrocytes through the Wnt/β-catenin signalling pathway.
    Ding QH; Qi YY; Li XM; Chen WP; Wang XH; Ji XW
    Int Immunopharmacol; 2019 Aug; 73():203-211. PubMed ID: 31103876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forced expression of KIAA1199, a novel hyaluronidase, inhibits tumorigenicity of low-grade chondrosarcoma.
    Koike H; Nishida Y; Shinomura T; Zhuo L; Hamada S; Ikuta K; Ito K; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2020 Sep; 38(9):1942-1951. PubMed ID: 32068299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
    Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization.
    Yoshida H; Nagaoka A; Kusaka-Kikushima A; Tobiishi M; Kawabata K; Sayo T; Sakai S; Sugiyama Y; Enomoto H; Okada Y; Inoue S
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5612-7. PubMed ID: 23509262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LDB1 overexpression is a negative prognostic factor in colorectal cancer.
    García SA; Swiersy A; Radhakrishnan P; Branchi V; Kanth Nanduri L; Győrffy B; Betzler AM; Bork U; Kahlert C; Reißfelder C; Rahbari NN; Weitz J; Schölch S
    Oncotarget; 2016 Dec; 7(51):84258-84270. PubMed ID: 27713177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.